Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for symptom improvement in irritable bowel syndrome patients with sleep disturbance
TCTR20210218002Phase 0Not yet recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of melatonin in irritable bowel syndrome (IBS) and sleep disorder, sponsored by Ratchadaphiseksomphot Endowment Fund. Planned start Apr 2021; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
irritable bowel syndrome (IBS)sleep disorder
Beyond the preview
Go deeper on TCTR20210218002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210218002.